
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2: from its discovery to genome structure, transcription, and replication
Ayslan Castro Brant, Wei Tian, Vladimır Majerčiak, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 218
Ayslan Castro Brant, Wei Tian, Vladimır Majerčiak, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 218
Showing 1-25 of 218 citing articles:
Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb
Mona Khan, Seung‐Jun Yoo, Marnick Clijsters, et al.
Cell (2021) Vol. 184, Iss. 24, pp. 5932-5949.e15
Open Access | Times Cited: 328
Mona Khan, Seung‐Jun Yoo, Marnick Clijsters, et al.
Cell (2021) Vol. 184, Iss. 24, pp. 5932-5949.e15
Open Access | Times Cited: 328
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 214
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 214
SARS‐CoV‐2 variants and vulnerability at the global level
Vivek P. Chavda, Aayushi Patel, Darsh D. Vaghasiya
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 2986-3005
Open Access | Times Cited: 108
Vivek P. Chavda, Aayushi Patel, Darsh D. Vaghasiya
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 2986-3005
Open Access | Times Cited: 108
Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19
Jiantao Zhang, Amara Ejikemeuwa, Volodymyr Gerzanich, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 104
Jiantao Zhang, Amara Ejikemeuwa, Volodymyr Gerzanich, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 104
Roles and functions of SARS-CoV-2 proteins in host immune evasion
Farooq Rashid, Zhixun Xie, Muhammad Suleman, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 99
Farooq Rashid, Zhixun Xie, Muhammad Suleman, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 99
Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions
Ahmed I. Abulsoud, Hussein M. El‐Husseiny, Ahmed A. El-Husseiny, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113977-113977
Open Access | Times Cited: 88
Ahmed I. Abulsoud, Hussein M. El‐Husseiny, Ahmed A. El-Husseiny, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113977-113977
Open Access | Times Cited: 88
Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China
Liyan Yang, Zhonglei Wang
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115503-115503
Open Access | Times Cited: 63
Liyan Yang, Zhonglei Wang
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115503-115503
Open Access | Times Cited: 63
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants
Ann‐Kathrin Reuschl, Lucy Thorne, Matthew Whelan, et al.
Nature Microbiology (2024) Vol. 9, Iss. 2, pp. 451-463
Open Access | Times Cited: 41
Ann‐Kathrin Reuschl, Lucy Thorne, Matthew Whelan, et al.
Nature Microbiology (2024) Vol. 9, Iss. 2, pp. 451-463
Open Access | Times Cited: 41
The E3 ligase RNF5 restricts SARS-CoV-2 replication by targeting its envelope protein for degradation
Zhaolong Li, Pengfei Hao, Zhilei Zhao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 40
Zhaolong Li, Pengfei Hao, Zhilei Zhao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 40
Basophils and Mast Cells in COVID-19 Pathogenesis
Giuseppe Murdaca, Mario Di Gioacchino, Mónica Greco, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2754-2754
Open Access | Times Cited: 60
Giuseppe Murdaca, Mario Di Gioacchino, Mónica Greco, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2754-2754
Open Access | Times Cited: 60
The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies
Shilei Zhang, Lulan Wang, Genhong Cheng
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1869-1884
Open Access | Times Cited: 58
Shilei Zhang, Lulan Wang, Genhong Cheng
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1869-1884
Open Access | Times Cited: 58
Longitudinal monitoring of SARS-CoV-2 in wastewater using viral genetic markers and the estimation of unconfirmed COVID-19 cases
Lin Li, Lauren Mazurowski, Aimee Dewan, et al.
The Science of The Total Environment (2022) Vol. 817, pp. 152958-152958
Open Access | Times Cited: 57
Lin Li, Lauren Mazurowski, Aimee Dewan, et al.
The Science of The Total Environment (2022) Vol. 817, pp. 152958-152958
Open Access | Times Cited: 57
Immunosenescence and COVID-19
Jacek M. Witkowski, Tamàs Fülöp, Ewa Bryl
Mechanisms of Ageing and Development (2022) Vol. 204, pp. 111672-111672
Open Access | Times Cited: 55
Jacek M. Witkowski, Tamàs Fülöp, Ewa Bryl
Mechanisms of Ageing and Development (2022) Vol. 204, pp. 111672-111672
Open Access | Times Cited: 55
Emerging SARS-CoV-2 variants: Why, how, and what's next?
Yu Chen, Qianyun Liu, Li Zhou, et al.
Cell Insight (2022) Vol. 1, Iss. 3, pp. 100029-100029
Open Access | Times Cited: 47
Yu Chen, Qianyun Liu, Li Zhou, et al.
Cell Insight (2022) Vol. 1, Iss. 3, pp. 100029-100029
Open Access | Times Cited: 47
Emergence of SARS-CoV-2 Variants in the World: How Could This Happen?
Alfredo Parra-Lucares, Paula Segura, Verónica Rojas, et al.
Life (2022) Vol. 12, Iss. 2, pp. 194-194
Open Access | Times Cited: 42
Alfredo Parra-Lucares, Paula Segura, Verónica Rojas, et al.
Life (2022) Vol. 12, Iss. 2, pp. 194-194
Open Access | Times Cited: 42
Spike protein mediated membrane fusion during SARS‐CoV‐2 infection
Xinyu Li, Huijun Yuan, Xiaozhen Li, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 42
Xinyu Li, Huijun Yuan, Xiaozhen Li, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 42
Generation and Functional Analysis of Defective Viral Genomes during SARS-CoV-2 Infection
Terry Zhou, Nora J. Gilliam, Sizhen Li, et al.
mBio (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 26
Terry Zhou, Nora J. Gilliam, Sizhen Li, et al.
mBio (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 26
Structural biology of SARS-CoV-2 Mpro and drug discovery
Yinkai Duan, Haofeng Wang, Zhenghong Yuan, et al.
Current Opinion in Structural Biology (2023) Vol. 82, pp. 102667-102667
Closed Access | Times Cited: 22
Yinkai Duan, Haofeng Wang, Zhenghong Yuan, et al.
Current Opinion in Structural Biology (2023) Vol. 82, pp. 102667-102667
Closed Access | Times Cited: 22
Recent Advances in Electrochemical and Nanophotonic Biosensors for SARS-CoV-2 Detection
Yeon Kyung Lee, Hyun Seok Song
BioChip Journal (2024) Vol. 18, Iss. 2, pp. 171-185
Open Access | Times Cited: 7
Yeon Kyung Lee, Hyun Seok Song
BioChip Journal (2024) Vol. 18, Iss. 2, pp. 171-185
Open Access | Times Cited: 7
Diagnostic assay and technology advancement for detecting SARS-CoV-2 infections causing the COVID-19 pandemic
B. Dhar
Analytical and Bioanalytical Chemistry (2022) Vol. 414, Iss. 9, pp. 2903-2934
Open Access | Times Cited: 33
B. Dhar
Analytical and Bioanalytical Chemistry (2022) Vol. 414, Iss. 9, pp. 2903-2934
Open Access | Times Cited: 33
COVID-19 Therapeutic Potential of Natural Products
Zhaoxuan Low, Rafidah Lani, Vunjia Tiong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9589-9589
Open Access | Times Cited: 19
Zhaoxuan Low, Rafidah Lani, Vunjia Tiong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9589-9589
Open Access | Times Cited: 19
Targeting SARS-CoV-2 Non-Structural Proteins
W.G. Tam, Ana C. Lorenzo‐Leal, Luis R. Hernández, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 13002-13002
Open Access | Times Cited: 16
W.G. Tam, Ana C. Lorenzo‐Leal, Luis R. Hernández, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 13002-13002
Open Access | Times Cited: 16
SARS-CoV-2 ORF3a Protein as a Therapeutic Target against COVID-19 and Long-Term Post-Infection Effects
Jiantao Zhang, Kellie Hom, Chen‐Yu Zhang, et al.
Pathogens (2024) Vol. 13, Iss. 1, pp. 75-75
Open Access | Times Cited: 5
Jiantao Zhang, Kellie Hom, Chen‐Yu Zhang, et al.
Pathogens (2024) Vol. 13, Iss. 1, pp. 75-75
Open Access | Times Cited: 5
Impact of COVID-19 on Ocular Surface Health: Infection Mechanisms, Immune Modulation, and Inflammatory Responses
Duliurui Huang, Weixia Xuan, Zhijie Li
Viruses (2025) Vol. 17, Iss. 1, pp. 68-68
Open Access
Duliurui Huang, Weixia Xuan, Zhijie Li
Viruses (2025) Vol. 17, Iss. 1, pp. 68-68
Open Access
Azadirachta Indica Phytoconstituents as Novel Inhibitors for Main Proteases of COVID-19: Molecular Dynamics and Simulation Study
Ubaida Hussain, Fatima Gillani, Laiba Gull, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 1, pp. 74-84
Closed Access
Ubaida Hussain, Fatima Gillani, Laiba Gull, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 1, pp. 74-84
Closed Access